Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40
ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients
Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival
Researchers Link Cancer Risk And DMPA Birth Control Use
Breast-Conserving Procedures Lead To Frequent Follow-up Care
False-Positive Mammograms Can Indicate Higher Cancer Risk
Proposed Surveillance Model Aims To Reduce Post-Treatment Pain
Adding Avastin Did Not Improve Standard Chemotherapy Regimen
Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas
Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial
Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options
Translplants Not Best Choice in Subset of ALL Patients
PET Response Can Predict Increased Survival In Patients
Cancer Incidence Rates Climb In HIV-Positive Female Populations
Technology Isolates and Recovers Circulating Liver Tumor Cells
Survey Shows That One-Third Of Patients Are Undertreated
Trials Approved by NCI CTEP For the Month of April
FDA Approves Votrient For Soft Tissue Sarcomas
Trending Stories
- As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer
- Trump 2016: A look back at the 45th president’s impact on oncology
- Ready or not, AI-based decision support tools are entering oncology clinics
Regulators and health systems must adapt - Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.” - A clinic at Fred Hutch addresses sexual health needs of patients with breast cancer
Data indicate low adherence to ASCO guideline
